Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $50.89 in the prior trading day, Mirum Pharmaceuticals Inc (NASDAQ: MIRM) closed at $48.39, down -4.91%. In other words, the price has decreased by -$4.91 from its previous closing price. On the day, 0.74 million shares were traded. MIRM stock price reached its highest trading level at $50.71 during the session, while it also had its lowest trading level at $48.235.
Ratios:
Our goal is to gain a better understanding of MIRM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.04 and its Current Ratio is at 3.22. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.35.
On April 17, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $48.
H.C. Wainwright reiterated its Buy rating for the stock on December 18, 2023, while the target price for the stock was revised from $60 to $58.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 11 ’25 when Fairey William sold 3,203 shares for $48.42 per share. The transaction valued at 155,091 led to the insider holds 2,500 shares of the business.
WILLIAM C FAIREY bought 3,203 shares of MIRM for $155,091 on Jun 11 ’25. On Jun 02 ’25, another insider, Ramasastry Saira, who serves as the Director of the company, sold 5,703 shares for $46.20 each. As a result, the insider received 263,492 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIRM now has a Market Capitalization of 2396984064 and an Enterprise Value of 2560303360. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.32 while its Price-to-Book (P/B) ratio in mrq is 10.26. Its current Enterprise Value per Revenue stands at 6.751 whereas that against EBITDA is -48.95.
Stock Price History:
The Beta on a monthly basis for MIRM is 0.97, which has changed by 0.4282763 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, MIRM has reached a high of $54.23, while it has fallen to a 52-week low of $33.45. The 50-Day Moving Average of the stock is 6.22%, while the 200-Day Moving Average is calculated to be 9.77%.
Shares Statistics:
The stock has traded on average 434.14K shares per day over the past 3-months and 492540 shares per day over the last 10 days, according to various share statistics. A total of 49.45M shares are outstanding, with a floating share count of 40.03M. Insiders hold about 19.18% of the company’s shares, while institutions hold 93.48% stake in the company. Shares short for MIRM as of 1749772800 were 6218308 with a Short Ratio of 14.32, compared to 1747267200 on 6287171. Therefore, it implies a Short% of Shares Outstanding of 6218308 and a Short% of Float of 12.550001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0